Table 3.
Variable | β | SE | Wald X2 | OR | p | 95% CI | |
---|---|---|---|---|---|---|---|
MACE | |||||||
Cardiogenic shock | 1.790 | 0.581 | 9.485 | 5.988 | 0.002 | 1.917 | 18.702 |
Malignant arrhythmias | 1.601 | 0.466 | 11.807 | 4.959 | 0.001 | 1.989 | 12.362 |
Age ≥ 75 years | 1.126 | 0.492 | 5.238 | 3.083 | 0.022 | 1.175 | 8.084 |
Death | |||||||
Cardiogenic shock | 2.871 | 0.595 | 23.266 | 17.663 | < 0.001 | 5.500 | 56.726 |
Malignant arrhythmias | 1.539 | 0.585 | 6.929 | 4.659 | 0.008 | 1.481 | 14.653 |
Variables in adjusted model were age (≥ 75), gender, BMI (≥ 30), smoking, DTB, operation time, hospital stay, DES (drug eluting stent), IABP use, final TIMI-3, diabetes, hypertension, hyperlipidemia, Takotsubo syndrome, cardiogenic shock, malignant arrhythmias, heart failure and grouping (2019 group vs COVID-19 group).